Stockreport

Trevi Therapeutics to Participate in Upcoming April Investor Conferences [Yahoo! Finance]

Trevi Therapeutics, Inc.  (TRVI) 
PDF investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF) and refractory chronic coug [Read more]